BARINTHUS BIOTHERAPEUTICS PLC Payments of Stock Issuance Costs
BARINTHUS BIOTHERAPEUTICS PLC (BRNS) reported Payments of Stock Issuance Costs of $2.17 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2023-03-24
- BARINTHUS BIOTHERAPEUTICS PLC payments of stock issuance costs for the quarter ending 2021-12-31 was $0.00.
- BARINTHUS BIOTHERAPEUTICS PLC payments of stock issuance costs for the quarter ending 2021-09-30 was $1.39M.
- BARINTHUS BIOTHERAPEUTICS PLC payments of stock issuance costs for the quarter ending 2021-06-30 was $756.00K.
- BARINTHUS BIOTHERAPEUTICS PLC payments of stock issuance costs for the quarter ending 2021-03-31 was $22.00K.
- BARINTHUS BIOTHERAPEUTICS PLC payments of stock issuance costs for fiscal 2021 was $2.17M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $1.39M derived: sum of 2 quarters · filed 2023-03-24 | $2.14M derived: sum of 3 quarters · filed 2023-03-24 | $2.17M 10-K · filed 2023-03-24 |
| 2021-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.14M derived: sum of 2 quarters · filed 2022-11-10 | $2.17M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $756.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $778.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $22.00K 10-Q · filed 2022-05-11 |